"NIH is considering additional funding for blastomere-derived lines" is taken from Rabin's 4th slide from the presentation a few days ago--is it a fact? I want to believe it is a fact since Rabin put it on slide and said it in public--but I do have a bias and so does Rabin.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.